TY - JOUR T1 - The impact of COVID-19 non-pharmaceutical interventions on the lived experiences of people living in Thailand, Malaysia, Italy and the United Kingdom: a cross-country qualitative study JF - medRxiv DO - 10.1101/2021.05.13.21257162 SP - 2021.05.13.21257162 AU - Mira L. Schneiders AU - Bhensri Naemiratch AU - Phaik Kin Cheah AU - Giulia Cuman AU - Tassawan Poomchaichote AU - Supanat Ruangkajorn AU - Silvia Stoppa AU - Anne Osterrieder AU - Phee-Kheng Cheah AU - Darlene Ongkili AU - Wirichada Pan-ngum AU - Constance R.S. Mackworth-Young AU - Phaik Yeong Cheah Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/05/14/2021.05.13.21257162.abstract N2 - This qualitative study explores the impact of non-pharmaceutical interventions (NPIs) on lived experiences during the first wave of the COVID-19 pandemic on people’s lives in Thailand, Malaysia, Italy and the United Kingdom. A total of 86 interviews were conducted with members of the public, including healthcare workers. Participants across countries held strong views on NPIs, with many feeling measures lacked clarity. Most participants reported primarily negative impacts of NPIs on their lives, including through separation, isolation and grief over missed milestones; work-related challenges and income loss; and poor mental health and wellbeing. Nonetheless, many also experienced inadvertent positive consequences, including more time at home to focus on what they most valued in life; a greater sense of connectedness; and benefits to working life. Commonly employed coping strategies focused on financial coping; psycho-emotional coping; social coping and connectedness; reducing and mitigating risks; and limiting exposure to the news. Importantly, the extent to which participants’ lived experiences were positive or negative, and their ability to cope was underpinned by individual, social and economic factors. In order to mitigate negative and unequal impacts of NPIs, COVID-19 policies will benefit from paying closer attention to the social, cultural and psychological—not just biological—vulnerabilities to, and consequences of public health measures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was funded by the Wellcome Trust through a Translation Partnership Award [210599] and a Wellcome Trust Strategic Award [096527]. For the purpose of open access, the author has applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. The Mahidol Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust [106698]. This study was also supported by the Sonar-Global project which has received funding from the European Union Horizon 2020 Research and Innovation Program [825671]. In Italy, the study was by supported by the Fondazione Nord-Est and Fondazione Cariparo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was granted by Oxford Tropical Research Ethics Committee (OxTREC, reference no.520-20), covering all four countries. Additional ethics committee approval from Italy was not required for the study to be conducted there. In Thailand, additional approval was sought from the Faculty of Tropical Medicine Ethics Committee (FTMEC, ref: MUTM 2020-031-01). In Malaysia, additional approval was granted by the Medical Research and Ethics Committee (MREC), the Ministry of Health Malaysia (MOH ref: NMRR-20-595-54437 (IIR)), and the Universiti Tunku Abdul Rahman (UTAR) Scientific and Ethical Review Committee (SERC, ref: (U/SERC/63/2020).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll relevant data are within the manuscript and its Supporting Information files. Complete interview data cannot be made publicly available due to ethical and legal reasons. Upon reasonable request, a list of condensed meaning units or codes can be made available on request to the MORU Data Access Committee (see link https://www.tropmedres.ac/units/moru-bangkok/bioethics-engagement/data-sharing). ER -